Almost 50,000 lung cancer patients have not been seen on time over the last 10 years, with thousands currently waiting more ...

The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been ...

“I really can’t stress the importance of early detection enough,” he says. “Catching it early can literally add years and ...

An FDA-designated orphan drug that can target a key vulnerability in lung cancer shows promise in improving the efficacy of ...

How one man, along with his care team, turned an all-consuming cancer diagnosis into a management strategy with inspiration ...

Opdivo (nivolumab) is a brand-name IV infusion prescribed for non-small cell lung cancer (NSCLC ... refers to the length of time people lived while receiving treatment. Another trial found ...

Researchers have shown that activation of the protein YAP, known to help cancer cells survive treatment, behaves very ...

"Lung cancer is notoriously awful because when it is found, a lot of the time it is Stage 3 and 4, which is hard to treat, ...

Preventing this complication for those who receive a lung transplant is of the highest priority, as there ... Experimental Cancer Drug Could Streamline Standard Tuberculosis Treatment and Prevent ...

The "Shanghai solution" — pleuroscopy-assisted early lung cancer ... of the treatment, said the doctors. Car praised the top-notch medical experience in Shanghai. "The first time when I saw ...

Enhertu plus Perjeta demonstrated improvement in progression-free survival versus standard treatment in HER2-positive ...